US4420470A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Percutaneous absorption type pharmaceutical preparation of isosorbide dinitrate or pentaerythritol tetranitrate in pressure-sensitive laminate
Assignee: Toa Eiyo Ltd
•
Filing: 1982-01-08
•
Granted: 1983-12-13
•
Expires: 2002-01-08
Abstract
Abstract A pharmaceutical preparation comprising a flexible backing and a base material provided thereon is described wherein the base material consists essentially of a polymer having a glass transition temperature of from -70 DEG C. to -10 DEG C. and exhibiting pressure-sensitivity at room temperature, and isosorbide dinitrate or pentaerythritol tetranitrate. This pharmaceutical preparation is applied to the skin, and permits the active ingredient to be absorbed through the skin into the body at a constant rate, and gradually over a long period of time.
Inventors
- 👤 Saburo Otsuka
- 👤 Toshiyuki Yoshikawa
- 👤 Shoichi Tokuda
- 👤 Yuuseke Ito
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-27 05:10
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/70; A61K9/7023; A61K9/703; A61K9/7038; A61K9/7046; A61K9/7053; A61K9/7061; A61K9/7076; A61P; A61P9/00; A61P9/08; A61P9/10
Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
134 words
A pharmaceutical preparation comprising a flexible backing and a base material formed on the flexible backing, said base material comprising a layer of a polymer having a glass transition temperature (Tg) of from -70° C. to -10° C. and exhibiting pressure-sensitivity at room temperature, and isosorbide dinitrate (ISDN) or pentaerythritol tetranitrate (PETN) retained in said base material, wherein the polymer contains at least 50% by weight alkyl acrylate or methacrylate containing an average of at least 4 carbon atoms in the alkyl moiety, wherein the isosorbide dinitrate or pentaerythritol tetranitrate concentration in the base material is from 0.5 to 20% by weight and wherein the laminate is composed of a polyester and a member selected from an ethylene-vinylacetate copolymer and an ethylene-ethylacrylate copolymer which prevents the crystallization of the isosorbide dinitrate or pentaerythritol tetranitrate.
Claim 2
Dependent Claim
134 words
A pharmaceutical preparation comprising a flexible backing and a base material formed on the flexible backing, said base material comprising a layer of a polymer having a glass transition temperature (Tg) of from -70° C. to -10° C. and exhibiting pressure-sensitivity at room temperature, and isosorbide dinitrate (ISDN) or pentaerythritol tetranitrate (PETN) retained in said base material, wherein the polymer contains at least 50% by weight alkyl acrylate or methacrylate containing an average of at least 4 carbon atoms in the alkyl moiety, wherein the isosorbide dinitrate or pentaerythritol tetranitrate concentration in the base material is from 0.5 to 20% by weight and wherein the laminate is composed of a polyester and a member selected from an ethylene-vinylacetate copolymer and an ethylene-ethylacrylate copolymer which prevents the crystallization of the isosorbide dinitrate or pentaerythritol tetranitrate.
Claim 3
Dependent Claim
24 words
A pharmaceutical preparation as in claim 1, wherein the polymer is a copolymer of alkyl acrylate or methacrylate and a functional monomer copolymerizable therewith.
Claim 4
Dependent Claim
25 words
A pharmaceutical preparation as in claim 2, wherein the polymer is a copolymer of alkyl acrylate or methacrylate and a vinyl ester monomer copolymerizable therewith.
Claim 5
Dependent Claim
16 words
A pharmaceutical preparation as in claim 1, wherein the base material further contains an absorption promotor.
Claim 6
Dependent Claim
31 words
A pharmaceutical preparation as in claim 1, wherein the base material comprises a plurality of base materials, each of which is composed of a polymer having a different glass transition temperature.
Claim 7
Dependent Claim
25 words
A pharmaceutical preparation as in claim 1, 2, 3, 4, or 5, wherein the glass transition temperature (Tg) is from -55° C. to -25° C.
Claim 8
Dependent Claim
26 words
A pharmaceutical preparation as in claim 1, wherein the isosorbide dinitrate or pentaerythritol tetranitrate concentration in the base material is from 2 to 15% by weight.
Claim 9
Dependent Claim
25 words
A pharmaceutical preparation as in claim 1, 2, 3, 4, or 5, wherein the thickness of the base material is from 5 to 300 μm.
Claim 10
Dependent Claim
20 words
A pharmaceutical preparation as in claim 6, wherein the thickness of the base material is from 5 to 300 μm.
Claim 11
Dependent Claim
20 words
A pharmaceutical preparation as in claim 7, wherein the thickness of the base material is from 5 to 300 μm.
Claim 12
Dependent Claim
13 words
A pharmaceutical preparation as in claim 1, wherein the backing is a laminate.
References Cited (Backward Citations)
US3742951A
Cited
US3742951B1
Cited
US3972995A
Cited
JPS5218813A
Cited
GB2021610A
Cited
GB2021950A
Cited
JPS55122714A
Cited
US4291015A
Cited
GB2073588A
Cited
US4336243A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1986-12-12 | 1987-06-13 | 1987-12-13 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1990-12-12 | 1991-06-13 | 1991-12-13 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1994-12-12 | 1995-06-13 | 1995-12-13 | $7700.00 | Window Closed / Lapsed |